Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingwen for suspected COVID-19
ChiCTR2000029433Phase 4Completed
- Sponsor
- Hebei Yiling Hospital
- Start
- Feb 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Lianhua Qingwen in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hebei Yiling Hospital. Primary endpoint: Clinical symptoms recovery rate and recovery time. Started Feb 2020; status: completed.
02
Drugs
Lianhua Qingwen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2000029433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029433.